Aurenar
PrivateLast Round
Seed
Jul 28, 2026
Total Funding Raised
$5.7M
Company Overview
Aurenar is a medical device company that develops a non-invasive, single-use neuromodulation platform designed to reduce life-threatening complications in intensive care unit patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aurenar Comparables
Compare Aurenar with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evren Technologies | 65% | |
| Spark Biomedical Inc | 62% | |
| Surf Therapeutics | 61% | |
Aurenar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 28, 2026 |
Key People
Founding team and executive leadership
Aurenar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaleida Capital | Seed |
| Solas BioVentures | Seed |
Aurenar Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aurenar's valuation, stock price, and market status.